Journey Medical (NASDAQ:DERM – Get Free Report) and Mannatech (NASDAQ:MTEX – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, earnings, risk, analyst recommendations, institutional ownership, dividends and valuation.
Institutional and Insider Ownership
7.3% of Journey Medical shares are owned by institutional investors. Comparatively, 13.0% of Mannatech shares are owned by institutional investors. 15.0% of Journey Medical shares are owned by insiders. Comparatively, 41.5% of Mannatech shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
Valuation & Earnings
This table compares Journey Medical and Mannatech”s gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Journey Medical | $56.13 million | 3.81 | -$14.67 million | ($0.35) | -22.51 |
| Mannatech | $117.87 million | 0.13 | $2.49 million | ($0.86) | -9.69 |
Mannatech has higher revenue and earnings than Journey Medical. Journey Medical is trading at a lower price-to-earnings ratio than Mannatech, indicating that it is currently the more affordable of the two stocks.
Analyst Recommendations
This is a summary of recent ratings and recommmendations for Journey Medical and Mannatech, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Journey Medical | 1 | 1 | 3 | 0 | 2.40 |
| Mannatech | 1 | 0 | 0 | 0 | 1.00 |
Journey Medical presently has a consensus target price of $12.17, suggesting a potential upside of 54.40%. Given Journey Medical’s stronger consensus rating and higher possible upside, research analysts clearly believe Journey Medical is more favorable than Mannatech.
Profitability
This table compares Journey Medical and Mannatech’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Journey Medical | -14.58% | -39.94% | -10.45% |
| Mannatech | -1.50% | -22.75% | -4.75% |
Risk & Volatility
Journey Medical has a beta of 0.8, meaning that its stock price is 20% less volatile than the S&P 500. Comparatively, Mannatech has a beta of 0.79, meaning that its stock price is 21% less volatile than the S&P 500.
Summary
Mannatech beats Journey Medical on 8 of the 14 factors compared between the two stocks.
About Journey Medical
Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant nodular acne; and Amzeeq, a topical formulation of minocycline for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris. It also offers Zilxi, a topical minocycline treatment for inflammatory lesions of rosacea; Exelderm cream and solution an antifungal intended for topical use; Targadox, an oral doxycycline drug for adjunctive therapy for severe acne; and Luxamend, a water-based emulsion formulated to provide a moist healing environment for superficial wounds; minor cuts or scrapes; dermal ulcers; donor sites; first- and second-degree burns, including sunburns; and radiation dermatitis. In addition, the company sells sulconazole nitrate cream and solution indicated for the treatment of tinea cruris, tinea corporis, and tinea versicolor; and doxycycline hyclate tablets, as an adjunctive therapy for severe acne. The company was formerly known as Coronado Dermatology, Inc. and changed its name to Journey Medical Corporation. Journey Medical Corporation was incorporated in 2014 and is headquartered in Scottsdale, Arizona. Journey Medical Corporation is a subsidiary of Fortress Biotech, Inc.
About Mannatech
Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels. Mannatech, Incorporated was incorporated in 1993 and is headquartered in Flower Mound, Texas.
Receive News & Ratings for Journey Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Journey Medical and related companies with MarketBeat.com's FREE daily email newsletter.
